Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Amlodipine/Atorvastatin 10mg/80mg vs Caduet
NCT02295046Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Oct 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of amlodipine + atorvastatin in hypertension (HTN) and hypercholesterolemia (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area under curve at 72.00 hours. Started Oct 2011; status: completed.
02
Drugs
amlodipine + atorvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02295046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02295046.